Genpact (G) Competitors $39.64 -0.15 (-0.36%) As of 11:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock G vs. CCRN, BR, GPN, JKHY, EXLS, WEX, MMS, PAY, EEFT, and WUShould you be buying Genpact stock or one of its competitors? The main competitors of Genpact include Cross Country Healthcare (CCRN), Broadridge Financial Solutions (BR), Global Payments (GPN), Jack Henry & Associates (JKHY), ExlService (EXLS), WEX (WEX), Maximus (MMS), Paymentus (PAY), Euronet Worldwide (EEFT), and Western Union (WU). Genpact vs. Its Competitors Cross Country Healthcare Broadridge Financial Solutions Global Payments Jack Henry & Associates ExlService WEX Maximus Paymentus Euronet Worldwide Western Union Cross Country Healthcare (NASDAQ:CCRN) and Genpact (NYSE:G) are related companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership. Which has better earnings & valuation, CCRN or G? Genpact has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.19B0.36-$14.56M-$0.26-50.50Genpact$4.77B1.45$513.67M$3.0113.18 Do insiders & institutionals have more ownership in CCRN or G? 96.0% of Cross Country Healthcare shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 4.9% of Cross Country Healthcare shares are owned by company insiders. Comparatively, 3.1% of Genpact shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is CCRN or G more profitable? Genpact has a net margin of 10.92% compared to Cross Country Healthcare's net margin of -0.70%. Genpact's return on equity of 22.15% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-0.70% 1.72% 1.24% Genpact 10.92%22.15%10.61% Which has more volatility & risk, CCRN or G? Cross Country Healthcare has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. Comparatively, Genpact has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Do analysts prefer CCRN or G? Cross Country Healthcare currently has a consensus target price of $17.93, indicating a potential upside of 36.56%. Genpact has a consensus target price of $51.13, indicating a potential upside of 28.87%. Given Cross Country Healthcare's higher probable upside, research analysts clearly believe Cross Country Healthcare is more favorable than Genpact.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Genpact 0 Sell rating(s) 6 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the media prefer CCRN or G? In the previous week, Genpact had 12 more articles in the media than Cross Country Healthcare. MarketBeat recorded 14 mentions for Genpact and 2 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 0.84 beat Genpact's score of 0.61 indicating that Cross Country Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Genpact 5 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGenpact beats Cross Country Healthcare on 13 of the 16 factors compared between the two stocks. Get Genpact News Delivered to You Automatically Sign up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart G vs. The Competition Export to ExcelMetricGenpactIT Services IndustryComputer SectorNYSE ExchangeMarket Cap$6.91B$238.54B$33.91B$22.06BDividend Yield1.71%1.77%3.19%3.59%P/E Ratio13.1833.58731.7133.00Price / Sales1.4535.831,529.0960.67Price / Cash11.0522.4037.2324.20Price / Book2.938.227.574.69Net Income$513.67M$365.78M$819.73M$1.01B7 Day Performance0.47%2.96%534.75%2.38%1 Month Performance-7.18%4.41%630.05%1.33%1 Year Performance3.25%234.95%24,480.48%13.62% Genpact Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GGenpact4.2668 of 5 stars$39.64-0.4%$51.13+29.0%+3.7%$6.92B$4.77B13.19140,000News CoveragePositive NewsAnalyst ForecastCCRNCross Country Healthcare3.4385 of 5 stars$12.50+7.9%$17.93+43.4%+8.0%$409.50M$1.34B-48.088,205BRBroadridge Financial Solutions4.7864 of 5 stars$232.87+0.0%$261.50+12.3%+7.3%$27.18B$6.89B32.8415,000Positive NewsGPNGlobal Payments4.9573 of 5 stars$84.24+1.7%$103.75+23.2%-12.4%$20.44B$10.07B14.7327,000Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionJKHYJack Henry & Associates4.723 of 5 stars$152.19+0.4%$174.88+14.9%-15.6%$11.06B$2.38B24.397,400Analyst ForecastEXLSExlService4.8801 of 5 stars$40.81-1.1%$51.33+25.8%+5.2%$6.59B$1.97B28.3459,500Upcoming EarningsWEXWEX4.0014 of 5 stars$150.44+0.1%$180.91+20.3%-24.8%$5.15B$2.63B19.026,500Upcoming EarningsAnalyst UpgradeMMSMaximus2.8296 of 5 stars$85.31-0.2%$90.00+5.5%+0.8%$4.81B$5.31B15.7141,100Positive NewsPAYPaymentus3.3734 of 5 stars$28.70-5.3%$37.00+28.9%+26.3%$3.59B$1.04B66.731,307EEFTEuronet Worldwide4.8172 of 5 stars$83.03-0.1%$121.17+45.9%-15.8%$3.40B$4.14B11.3910,600Trending NewsEarnings ReportAnalyst ForecastWUWestern Union4.113 of 5 stars$8.14+2.6%$8.50+4.5%-29.3%$2.63B$4.21B3.089,100Trending NewsEarnings ReportAnalyst ForecastOptions VolumeGap Up Related Companies and Tools Related Companies Cross Country Healthcare Competitors Broadridge Financial Solutions Competitors Global Payments Competitors Jack Henry & Associates Competitors ExlService Competitors WEX Competitors Maximus Competitors Paymentus Competitors Euronet Worldwide Competitors Western Union Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:G) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredApple's secret partnerThe Tiny Company Apple Can’t Live Without A tiny company holds the key to Apple’s biggest breakthrough sinc...The Oxford Club | SponsoredTrump cannot stop this trainGallup reports that two-thirds of Americans now view socialism favorably — a shocking shift that one analyst s...Porter & Company | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genpact Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Genpact With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
